Ashland Inc.

Fundamentals5.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong liquidity
  • High leverage
  • Improving cashflow

AI
AI Summary

6.0

Ashland has shifted from a cyclical chemicals play into a conditional recovery/turnaround driven by higher-margin Life Sciences and Personal Care growth plus a $90M manufacturing optimization program, but this re-rating hinges on flawless execution — specifically sequential EBITDA/FCF beats and visible deleveraging — to absorb legacy litigation and operational setbacks. Investors should monitor two consecutive quarters of EBITDA/FCF improvement trending to the top of the $400–$420M guidance, delivery of the $30M FY26 cost savings, and declining net leverage as clear triggers for upside (or persistent misses as triggers for downside).

LifeSciences
ExecutionRisk
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Strong liquidity
  • High leverage
  • Improving cashflow

ASH shows strong liquidity and improving quarterly cash generation but is undermined by heavy leverage and a large FY non‑cash charge that produced steep annual losses, signaling cautious hold unless operating recovery continues.

LiquidityStrong
HighLeverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month mean
  • Recent sharp decline
  • Defined support band

ASH is in a pronounced downtrend—trading at $48.81 (about 24% below the last-month high of $64.37) and well under the last-month mean (~$56.4), with near-term support $48.8–$51.0, resistance $61–$64 and continued downside risk unless price reclaims ~$56 and clears $61–$64.

bearish
meanreversion
Support Level: $48.8–$51.0
Resistance Level: $61–$64

~24% drop from $64.37 to $48.81 over the last month indicating pronounced short-term weakness

Sentiment & News

6.0

Key News Insights:

  • Activist involvement
  • Technical breakout
  • Mixed fund flows

Ashland is drawing renewed investor and analyst interest—buoyed by activist involvement, portfolio improvements and a move above the 200‑day MA—despite short‑term volatility.

ASH
specialtychemicals

Continued activist-driven upgrades and visible management engagement should support upside potential though expect near-term trading noise